1,791 results
·
35ms
·
Sources: EU EUDAMED, US FDA
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent Venous RP & Endoprosthesis with Unistep Plus
Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay
FDA Pre-Market Approval
FDA Class 3
·VENTANA MMR RxDx Panel
Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay
FDA Pre-Market Approval
FDA Class 3
·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Immunocytochemistry Assay, P16/Ki-67
FDA Pre-Market Approval
FDA Class 3
·CINtec PLUS Cytology
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (TIPS,ILAC,VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS (VENOUS)
Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay
FDA Pre-Market Approval
FDA Class 3
·VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status)
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent (Venous) Endoprosthesis with Unisteo Plus Delivery System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (VENOUS)ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent Venous Endoprosthesis with Unistep Plus Delivery System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent Venous Endoprosthesis with UNISTEP Plus
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDO (VENOUS) STENT SYTEM
Immunocytochemistry Assay, P16/Ki-67
FDA Pre-Market Approval
FDA Class 3
·CINtec PLUS Cytology
Immunocytochemistry Assay, P16/Ki-67
FDA Pre-Market Approval
FDA Class 3
·CINtec PLUS Cytology
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS VENOUS